PALISADE BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PALISADE BIO, INC. (PALI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 14 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-20
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-12-31 was 36.74K shares.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-06-30 was 141.00 shares.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-03-31 was 10.49K shares.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 14.00 shares, a 99.76% decline from fiscal 2024.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 5.90K shares, a 87.54% decline from fiscal 2023.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 47.37K shares, a 321.33% increase from fiscal 2022.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 11.24K shares, a 87.49% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 14.00 shares 10-K · filed 2026-03-20 | |||
| 2024-12-31 | 5.90K shares 10-K · filed 2025-03-24 | |||
| 2023-12-31 | 36.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 36.74K shares derived: sum of 2 quarters · filed 2024-03-26 | 36.88K shares derived: sum of 3 quarters · filed 2024-03-26 | 47.37K shares 10-K · filed 2024-03-26 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 141.00 shares derived: sum of 2 quarters · filed 2023-11-09 | 10.63K shares 10-Q · filed 2023-11-09 | -140.61K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 141.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 10.63K shares 10-Q · filed 2023-08-10 | -140.61K shares derived: sum of 3 quarters · filed 2023-08-10 | 21.87K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 10.49K shares 10-Q · filed 2023-05-11 | -140.75K shares derived: sum of 2 quarters · filed 2023-05-11 | 21.73K shares derived: sum of 3 quarters · filed 2023-05-11 | 21.73K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | -151.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 11.24K shares derived: sum of 2 quarters · filed 2023-03-22 | 11.24K shares derived: sum of 3 quarters · filed 2023-03-22 | 11.24K shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 162.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 162.48K shares derived: sum of 2 quarters · filed 2022-11-14 | 162.48K shares 10-Q · filed 2022-11-14 | 165.32K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 0.00 shares 10-Q · filed 2022-08-15 | 2.84K shares derived: sum of 3 quarters · filed 2022-08-15 | 5.74K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-13 | 2.84K shares derived: sum of 2 quarters · filed 2022-05-13 | 5.74K shares derived: sum of 3 quarters · filed 2022-05-13 | |
| 2021-12-31 | 2.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 5.74K shares derived: sum of 2 quarters · filed 2022-03-17 | 89.87K shares 10-K · filed 2022-03-17 | |
| 2021-09-30 | 2.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 87.03K shares 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | 84.13K shares 10-Q · filed 2021-08-23 | |||
| 2020-12-31 | 3.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | 160.75K shares 10-K · filed 2021-03-22 | ||
| 2020-09-30 | 157.20K shares 10-Q · filed 2020-11-10 | |||
| 2020-03-31 | 5.05K shares 10-Q · filed 2020-05-15 | 33.12K shares derived: sum of 2 quarters · filed 2020-05-15 | 40.72K shares derived: sum of 3 quarters · filed 2020-05-15 | |
| 2019-12-31 | 28.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | 35.67K shares derived: sum of 2 quarters · filed 2020-03-27 | 38.20K shares 10-K · filed 2020-03-27 | |
| 2019-09-30 | 7.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 10.13K shares 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | 2.53K shares 10-Q · filed 2019-08-14 | |||
| 2018-12-31 | 199.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 333.46K shares derived: sum of 2 quarters · filed 2019-03-22 | 424.61K shares derived: sum of 3 quarters · filed 2019-03-22 | 750.05K shares 10-K · filed 2019-03-22 |
| 2018-09-30 | 133.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 224.77K shares derived: sum of 2 quarters · filed 2018-11-14 | 550.22K shares 10-Q · filed 2018-11-14 | 543.02K shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 91.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 416.59K shares 10-Q · filed 2018-08-13 | 409.39K shares derived: sum of 3 quarters · filed 2018-08-13 | 446.10K shares derived: sum of 4 quarters · filed 2018-08-13 |
| 2018-03-31 | 325.44K shares 10-Q · filed 2018-05-15 | 318.25K shares derived: sum of 2 quarters · filed 2018-05-15 | 354.95K shares derived: sum of 3 quarters · filed 2018-05-15 | 362.64K shares derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | -7.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 29.51K shares derived: sum of 2 quarters · filed 2018-04-02 | 37.20K shares derived: sum of 3 quarters · filed 2018-04-02 | 44.89K shares 10-K · filed 2018-04-02 |
| 2017-09-30 | 36.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 44.40K shares derived: sum of 2 quarters · filed 2017-11-08 | 52.09K shares 10-Q · filed 2017-11-08 | -661.97K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 7.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 15.39K shares 10-Q · filed 2017-08-08 | -698.67K shares derived: sum of 3 quarters · filed 2017-08-08 | -138.56K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 7.69K shares 10-Q · filed 2017-05-10 | -706.36K shares derived: sum of 2 quarters · filed 2017-05-10 | -146.26K shares derived: sum of 3 quarters · filed 2017-05-10 | -34.29K shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -714.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -153.95K shares derived: sum of 2 quarters · filed 2017-03-23 | -41.98K shares derived: sum of 3 quarters · filed 2017-03-23 | 60.03K shares 10-K · filed 2017-03-23 |
| 2016-09-30 | 560.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 672.07K shares derived: sum of 2 quarters · filed 2016-11-08 | 774.08K shares 10-Q · filed 2016-11-08 | 1.16M shares derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | 111.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 213.98K shares 10-Q · filed 2016-08-11 | 597.31K shares derived: sum of 3 quarters · filed 2016-08-11 | 1.60M shares derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | 102.01K shares 10-Q · filed 2016-05-09 | 485.34K shares derived: sum of 2 quarters · filed 2016-05-09 | 1.49M shares derived: sum of 3 quarters · filed 2016-05-09 | 1.68M shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 383.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 1.38M shares derived: sum of 2 quarters · filed 2016-03-14 | 1.58M shares derived: sum of 3 quarters · filed 2016-03-14 | 1.62M shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 1.20M shares derived: sum of 2 quarters · filed 2015-11-09 | 1.23M shares 10-Q · filed 2015-11-09 | 1.23M shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 197.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 232.61K shares 10-Q · filed 2015-08-10 | 232.81K shares derived: sum of 3 quarters · filed 2015-08-10 | 240.66K shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 35.06K shares 10-Q · filed 2015-05-08 | 35.26K shares derived: sum of 2 quarters · filed 2015-05-08 | 43.11K shares derived: sum of 3 quarters · filed 2015-05-08 | 97.14K shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | 194.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 8.05K shares derived: sum of 2 quarters · filed 2015-03-16 | 62.08K shares derived: sum of 3 quarters · filed 2015-03-16 | 282.98K shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 7.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | 61.89K shares derived: sum of 2 quarters · filed 2014-11-07 | 282.79K shares 10-Q · filed 2014-11-07 | 333.83K shares derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | 54.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | 274.94K shares 10-Q · filed 2014-08-08 | 325.98K shares derived: sum of 3 quarters · filed 2014-08-08 | 325.98K shares derived: sum of 4 quarters · filed 2014-08-08 |
| 2014-03-31 | 220.90K shares 10-Q · filed 2014-05-12 | 271.94K shares derived: sum of 2 quarters · filed 2014-05-12 | 271.94K shares derived: sum of 3 quarters · filed 2014-05-12 | 271.94K shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 51.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | 51.04K shares derived: sum of 2 quarters · filed 2014-03-10 | 51.04K shares derived: sum of 3 quarters · filed 2014-03-10 | 51.04K shares 10-K · filed 2014-03-10 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-12 | 0.00 shares 10-Q · filed 2013-11-12 | 106.82K shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 0.00 shares 10-Q · filed 2013-08-08 | 106.82K shares derived: sum of 3 quarters · filed 2013-08-08 | 99.98K shares derived: sum of 4 quarters · filed 2013-08-08 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | 106.82K shares derived: sum of 2 quarters · filed 2013-05-10 | 99.98K shares derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | 106.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | 99.98K shares derived: sum of 2 quarters · filed 2013-03-15 | 53.41K shares 10-K · filed 2013-03-15 | |
| 2012-09-30 | -6.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -53.41K shares 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | -46.57K shares 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | 5.34K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |